Top News: Seventy Seven Energy Inc. (NYSE:SSE), The Coca-Cola Company (NYSE:KO), Aspen Aerogels (NYSE:ASPN), Johnson & Johnson (NYSE:JNJ), ERBA Diagnostics (NYSEMKT:ERB)


On Thursday shares of Seventy Seven Energy Inc. (NYSE:SSE) closed at $3.74. Company’s sales growth for last 5 years was 26.20%. Seventy Seven Energy Inc. (NYSE:SSE) announced that it will host its first Annual Meeting of Shareholders on Wednesday, June 3, 2015, in Oklahoma City. Additional details about the meeting, the shareholders who will be eligible to vote and the matters to be voted upon will be included in SSE’s forthcoming proxy materials.

On Thursday shares of The Coca-Cola Company (NYSE:KO) closed at $40.35. Company’s sales growth for last 5 years was 8.20% and EPS growth for next 5 years is recorded as 4.87%. The Coca-Cola Company (NYSE:KO) has invited 10 roster agencies from around the world to pitch ideas for its next big global campaign. A representative for the soft drinks giant said in a statement that “We have invited a selection of our key agencies from around the world to bring their best thinking to Coca-Cola in order to create the strongest work for our flagship brand”.

On last trading day Aspen Aerogels, Inc. (NYSE:ASPN) advanced 0.55% to close at $7.27. Its volatility for the week is 4.77% while volatility for the month is 4.34%. ASPN’s sales growth for past 5 years was 29.10% and its EPS growth for past 5 years was -38.60%. Aspen Aerogels, Inc. (NYSE:ASPN) monthly performance is -8.32%. Analysts at Citigroup Inc. initiated coverage on shares of Aspen Aerogels, Inc. (NYSE:ASPN) in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.

Johnson & Johnson (NYSE:JNJ) in last trading activity decreased -0.20% to close at $100.14. Company weekly performance is -1.52% while its quarterly performance stands at -3.30%. Johnson & Johnson (NYSE:JNJ) is -7.48% away from its 52 week high. Johnson & Johnson ((NYSE:JNJ)) has a Chinese strategy: long-term thinking. Despite an economic slowdown and regulatory crackdowns–and the example of other multinationals that have scaled back there–CEO Alex Gorsky figures it’s worth it to ride out the storm. In an interview with the state-owned news service Xinhua, Gorsky said China’s “new normal” will still be an attractive prospect for his company. Industry investments in the country are starting to pay off, so it’s no time to ratchet back now.

On last trading day ERBA Diagnostics, Inc. (NYSEMKT:ERB) advanced 4.36% to close at $3.83. Its volatility for the week is 8.71% while volatility for the month is 5.49%. ERB’s sales growth for past 5 years was 6.40%. ERBA Diagnostics, Inc. (NYSEMKT:ERB) monthly performance is 11.66%. ERBA Diagnostics, Inc. (NYSEMKT:ERB) announced that its wholly-owned subsidiary – Diamedix Corporation – has entered into a purchase and sale agreement to sell its former facilities located in Miami, Florida, for $23 million. ERBA Diagnostics intends to use the net proceeds from the sale of the property for potential facilities purchases, potential strategic acquisitions and for general working capital.


Leave a Reply

Your email address will not be published. Required fields are marked *